Hedgehog Signaling Pathway in Ovarian Cancer

Despite advances in surgical and chemotherapeutic treatment options, less than 50% of patients with advanced-stage ovarian cancer survive five years after initial diagnosis. In this regard, novel treatment approaches are warranted utilizing molecularly targeted therapies directed against particular...

Descripción completa

Detalles Bibliográficos
Autores principales: Szkandera, Joanna, Kiesslich, Tobias, Haybaeck, Johannes, Gerger, Armin, Pichler, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565315/
https://www.ncbi.nlm.nih.gov/pubmed/23303278
http://dx.doi.org/10.3390/ijms14011179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565315/
https://www.ncbi.nlm.nih.gov/pubmed/23303278
http://dx.doi.org/10.3390/ijms14011179

Ejemplares similares